R Scott Wright News Today

While there was less MACE with inclisiran, only future outcome trials will determine the drug’s ability to reduce CVD events.

Dr. Michael Joyner is suing Mayo Clinic for disciplinary actions against him for “problematic” statements and “unprofessional” behavior. His job reviews describe him as “a true innovator. Fearless."

ROCHESTER, Minn. — Mayo Clinic Dr. Michael Joyner is suing his employer for “punitive” discipline actions against him for “problematic” statements to the media, “unprofessional” behavior and what he claims to be retaliation for his role in a whistleblowing report. Joyner, an anesthesiologist and physiologist, has worked at Mayo Clinic since 1992 and has become […]

The well-known Mayo Clinic doctor claims he is entitled to the same freedom of speech rights as educators on college campuses due to Mayo Clinic categorizing itself with the IRS as an educational institution.

In combining multiple ORION studies, investigators showed that roughly 80% of high-risk patients got to treatment goals.

Veterans Today | Military Foreign Affairs Policy Journal for Clandestine Services Covid, Italian MD’s Plasma Therapy disparaged by Wikipedia but celebrated in US. “It Healed 95thousands Americans”, study Research on Johns Hopkins Bloomberg School of Public Health reveals the effectiveness of the therapy of the Italian doctor who died in a suspected suicide On August,2, in the Basilica of Mantua, to give the last sad farewell to Professor Giuseppe De Donno, there were no national authori...

What science has learned works and what doesn’t in COVID-19 treatments Karen Weintraub, USA TODAY © Jae C. Hong, AP Two nurses put a ventilator on a patient in a COVID-19 unit at St. Joseph Hospital in Orange, Calif., Jan. 7, 2021. A year after the first COVID-19 patient was treated in the United States, a number of medications and approaches have been studied and found effective, while others have shown little benefit. There are 394 treatments and 241 antivirals still be...

A year into treating those with COVID-19, research is revealing medical interventions, such as remdesivir, that help patients, and some that don’t.

A year into treating those with COVID-19, research is revealing medical interventions, such as remdesivir, that help patients, and some that don’t.

Treatment for COVID-19 is better than a year ago, but it still has a long way to go Karen Weintraub, USA TODAY © Scott Olson, Getty Images A patient receives treatment in the emergency room at Roseland Community Hospital in Chicago, Illinois. About one third of the patients that arrive in the ER at Roseland display symptoms of COVID-19. The Roseland neighborhood, on the citys far south side, is 95% black. The COVID-19 death rate among black residents in Chicago is nearly doub...